Pointe Capital Management’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $276K | Buy |
525
+6
| +1% | +$3.15K | 0.14% | 129 |
|
|
2025
Q1 | $329K | Sell |
519
-9
| -2% | -$5.71K | 0.19% | 114 |
|
|
2024
Q4 | $376K | Buy |
528
+187
| +55% | +$133K | 0.22% | 110 |
|
|
2024
Q3 | $358K | Buy |
+341
| New | +$358K | 0.21% | 112 |
|
|
2023
Q2 | – | Sell |
-132
| Closed | -$108K | – | 337 |
|
|
2023
Q1 | $108K | Buy |
+132
| New | +$108K | 0.08% | 181 |
|
|
2022
Q2 | – | Sell |
-571
| Closed | -$399K | – | 153 |
|
|
2022
Q1 | $399K | Buy |
571
+14
| +3% | +$9.78K | 0.25% | 100 |
|
|
2021
Q4 | $352K | Buy |
+557
| New | +$352K | 0.21% | 113 |
|